Early Rehabilitation Program is Feasible and Safe in ICU in Liver Transplanted Patients

Sponsor
Assistance Publique Hopitaux De Marseille (Other)
Overall Status
Unknown status
CT.gov ID
NCT01960868
Collaborator
(none)
40
1
2
18
2.2

Study Details

Study Description

Brief Summary

Liver transplantation is the last surgical treatment for patients with acute or chronic liver disease. Transplantation therapies technics are in constant evolution. It allows an increasing survivals rates and time to come back to daily activities. The postoperative treatment after abdominal surgery as Liver Transplantation (LT) is usually performed in Intensive Care Unit (ICU).This postoperative phase is one of the most important steps regarding the involvement of the rehabilitation of the patient (Rongies 2005). Physical abilities transplantation are likely to be important in the postoperative. It appears that pre-transplant subjects have a weakened muscle potential, they will increase it significantly in the months after transplantation with a rehabilitation program adapted (Beyer 1999). Length of stay in ICU depends on surgery complications. Inactivity induced by sedation and ICU length of stay are major factor for increasing complications as respiratory disorders and muscle weakness. Several studies have reported feasibility and safety an early mobility program in ICU, especially regarding the length of stay decrease (Bailey 2007; Morris 2008; Schweickret 2009, Needham 2010; Bourdin 2010) These early mobility programs encompass muscle strength assessment, passive range of motion, active mobility, sitting on the edge of bed, standing and walking, which would be related to the primary disease of LT (Rongies 2008). The assessment of the strength for ICU patient is feasible and reproducible with the Medical Research Council score (MRC score). The MRC score consists in an assessment of three muscle groups of upper and lower limbs. Sitting positions and verticalization are included in programs begun as soon as possible after surgery evaluation of the response level to verbal stimulation and physical abilities (Gosselink 2011). The skills of the physiotherapist are established in legal texts making him a key in the assessment and management of these patients on musculoskeletal and respiratory domains.

The purpose of this study is to validate data feasibility and tolerance. Another aim is also to assess the length of stay in ICU, of early mobility and physical program, started in the postoperative period in a population of patients with liver transplantation, during their stay in ICU of Prof. Albanese. Thus, we decided to carry out a parallel study, open, randomized monocentric comparing two groups of patient liver transplanted. The control group will receive the standard treatment used in the ICU and the experimental group will receive a protocol of early mobilization according to data from recent literature on the subject. The study is scheduled to last over one year and included patients will receive physical therapy on five days a week with a frequency of one to several times per day depending on the clinical requirements or conditions of the study.

Condition or Disease Intervention/Treatment Phase
  • Other: standard physiotherapy
  • Other: experimental physical therapy
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Early Rehabilitation Program is Feasible and Safe in ICU in Liver Transplanted Patients
Study Start Date :
Oct 1, 2013
Anticipated Primary Completion Date :
Oct 1, 2014
Anticipated Study Completion Date :
Apr 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Experimental: patients

Other: experimental physical therapy

Other: control group

Other: standard physiotherapy

Outcome Measures

Primary Outcome Measures

  1. Medical Research Council score (MRC score). [12 months]

    The assessment of the strength for ICU patient

Secondary Outcome Measures

  1. the length of stay in ICU, [12 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • patient more than 18 years,

  • patient for a liver transplant

  • patient that informed consent was obtained

Exclusion Criteria:
  • patient whose consent has not been obtained,

  • patient with major cons-indications to the application program (paralysis neuromyopathy majeure),

  • patient with hemodynamic instability or severe infection,

  • pregnant women,

  • nursing mothers,

  • persons deprived of their liberty by a judicial or administrative decision,

  • patient being a measure of legal protection,

  • patient requiring a transplant urgently

  • patient younger than 18 years.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Assistance Publique Hopitaux de Marseille Marseille France 13354

Sponsors and Collaborators

  • Assistance Publique Hopitaux De Marseille

Investigators

  • Study Director: LOIC MONDOLONI, Assistance Publique Hopitaux De Marseille

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Assistance Publique Hopitaux De Marseille
ClinicalTrials.gov Identifier:
NCT01960868
Other Study ID Numbers:
  • 2013-A00760-45
  • 2013-20
First Posted:
Oct 11, 2013
Last Update Posted:
Oct 11, 2013
Last Verified:
Oct 1, 2013

Study Results

No Results Posted as of Oct 11, 2013